"We believe Dechra is an ideal company to deliver results for Mirataz globally, given their expansive commercial footprint, proven success selling specialist products, and synergies between Mirataz ...

On May 7, 2018, the Company, which is a biopharmaceutical organization focused on saving and improving the lives of pets, declared that the US Food and Drug Administration (FDA)'s Center for ...

SAN FRANCISCO, July 9, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced ...

SAN FRANCISCO, Oct. 10, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (Nasdaq: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced ...

SAN FRANCISCO, April 15, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has ...

SAN FRANCISCO, Aug. 22, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the submission of ...

Kindred Biosciences, a biopharmaceutical company focused on saving and improving the lives of pets, has announced it has received a technical section complete letter for effectiveness from the US Food ...

Our feline friends often get excited about specific foods. Whenever a can of tuna is opened, cats come running! So when your cat doesn’t seem excited to eat — even something exciting like tuna — they ...

- Mirataz is the first and only medication approved in the European Union to treat cats experiencing poor appetite and weight loss resulting from chronic medical conditions. SAN FRANCISCO, Dec. 12, ...

SAN FRANCISCO, March 16, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has ...